The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment

被引:2
|
作者
Sahin, Mehmet Fatih [1 ,5 ]
Ozcan, Ridvan [2 ]
Malak, Arzu [3 ]
Dogan, Cagri [4 ]
Yazici, Cenk Murat [4 ]
Ozcan, Muege [4 ]
Akgul, Murat [4 ]
机构
[1] Corlu State Hosp, Dept Urol, Corlu, Tekirdag, Turkiye
[2] Bursa City Hosp, Dept Urol, Bursa, Nilufer, Turkiye
[3] Tekirdag Namik Kemal Univ, Sch Hlth, Nursing Dept, Suleymanpasa, Tekirdag, Turkiye
[4] Tekirdag Namik Kemal Univ, Med Sch, Dept Urol, Suleymanpasa, Tekirdag, Turkiye
[5] Corlu State Hosp, Dept Urol, TR-59850 Corlu, Tekirdag, Turkiye
关键词
anxiety; bladder pain syndrome; COVID-19; depression; INTERSTITIAL CYSTITIS; ANXIETY; WOMEN;
D O I
10.1002/nau.25199
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCOVID-19 is a disease that may cause anxiety, depression, and stress. Bladder pain syndrome (BPS) is a disease in which stress and psychological factors might negatively affect its course. In this study, we aimed to examine the possible clinical aggregation of the pandemic period on BPS patients. Materials and MethodsA total of 35 BPS patients diagnosed between 2010 and 2018 were included. All patients were using medical treatment, and the follow-up period was at least 6 months. According to our clinical follow-up protocol, the BPS patients were given the King's Health Questionnaire (KHQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Overactive Bladder Form V8 (OAB-V8), and Visual Analog Score (VAS) in every visit. In the sixth month of the pandemic, the clinical course of the patients was questioned by telephone or video interview, and their treatment continuities were questioned. Information was received about the delays in their follow-up and the difficulties in accessing healthcare opportunities. The same questionnaires were filled out and compared with pre-pandemic scores. ResultsThe mean age of the patients included in the study was 50.2 +/- 13.32 (min:20, max:74), 11 were males and 24 were females. The mean follow-up periods were 71.8 +/- 35.6 months. All questionnaire scores showed an increase compared to the pre-pandemic period. A statistically significant increase was detected during the pandemic in all sub-units of the KHQ. The VAS and OAB-V8 scores of 16 patients who requested hospital admission were significantly higher than before the pandemic. However, there was no statistically significant difference in the increase in VAS and OAB-V8 scores of the 19 patients who refused to come to the hospital. ConclusionBPS patients have been negatively affected by the emotional effects of the COVID-19 pandemic. Due to the fear, stress, anxiety, and depression, the symptoms of BPS patients exacerbated, and the patients could not receive the necessary support due to a lack of regular follow-ups.
引用
收藏
页码:1188 / 1193
页数:6
相关论文
共 50 条
  • [31] NON-BLADDER CONDITIONS IN FEMALE PATIENTS WITH BLADDER PAIN SYNDROME
    Fan, Y. H.
    Lin, A. T. L.
    Lu, S. H.
    Chuang, Y. C.
    Chen, K. K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 305 - 305
  • [32] Individualized treatment strategy for bladder pain syndrome in female patients provides treatment recipes for successful management
    Nickel, J. C.
    PROGRES EN UROLOGIE, 2023, 33 (07): : 359 - 361
  • [33] THE EFFECT OF PREGNANCY ON INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
    O'Hare, Peter, III
    El-Khawand, Dominique
    Morrissey, Darlene
    Whitmore, Kristene
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 210 - 210
  • [34] Spontaneous miscarriages in patients with bladder pain syndrome/interstitial cystitis - effect of stress on inflammation?
    Theoharides, T. C.
    Christodoulou, S.
    Athanasiou, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 5 - 10
  • [35] Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC)
    Hoke, Tanya P.
    Goldstein, Howard
    Saks, Emily K.
    Vakili, Babak
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (03) : 784 - 786
  • [36] Biomarkers for patients with interstitial cystitis/bladder pain syndrome
    Liu, Hsin-Tzu
    Kuo, Hann-Chorng
    UROLOGICAL SCIENCE, 2015, 26 (04) : 225 - 229
  • [37] The effect of covid-19 pandemic period on the treatment process of colorectal cancer patients
    Sahin, Enes
    Koeken, Hasim
    Yilmaz, Abdullah Hilmi
    Sahin, Kazim
    Yirmibesoglu, Oktay
    Guler, Sertac Ata
    Simsek, Turgay
    Utkan, Nihat Zafer
    Canturk, Nuh Zafer
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2025, 16 (03): : 182 - 186
  • [38] Beyond a Simple Anesthetic Effect: Lidocaine in the Diagnosis and Treatment of Interstitial Cystitis/bladder Pain Syndrome
    Henry, Richard A.
    Morales, Alvaro
    Cahill, Catherine M.
    UROLOGY, 2015, 85 (05) : 1025 - 1033
  • [39] Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome
    Furuta, Akira
    Suzuki, Yasuyuki
    Igarashi, Taro
    Koike, Yusuke
    Kimura, Takahiro
    Egawa, Shin
    Yoshimura, Naoki
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 35 - 40
  • [40] Amniotic bladder therapy in patients with recalcitrant interstitial cystitis and bladder pain syndrome
    Wittenberg, Sophie
    Madan, Raghav
    Liaw, Aron
    Lucas, Steven
    Hamada, Alaa
    Dhar, Nivedita
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2023, 17 (11): : E402 - E404